Terug
Dagbereik
€ 20,90
€ 24,70
52-Weeksbereik
€ 17,62
€ 28,10
Volume
92
50D / 200D Gem.
€ 25,37
/
€ 25,54
Vorige Slotkoers
€ 24,70
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 91,9 | 0,3 |
| P/B | 4,4 | 2,9 |
| ROE % | 4,7 | 3,7 |
| Net Margin % | 3,3 | 3,8 |
| Rev Growth 5Y % | 7,0 | 10,0 |
| D/E | 0,5 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 1,09
€ 1,06 – € 1,13
|
290 M | 1 |
| FY2027 |
€ 0,97
€ 0,95 – € 1,01
|
270 M | 1 |
| FY2026 |
€ 0,87
€ 0,84 – € 0,90
|
250 M | 1 |
Belangrijkste Punten
Revenue grew 7,01% annually over 5 years — modest growth
Earnings grew 162,77% over the past year
ROE of 4,74% is below average
Debt/Equity of 0,49 — conservative balance sheet
Generating 15,65M in free cash flow
P/E of 91,85 — premium valuation
Groei
Revenue Growth (5Y)
7,01%
Revenue (1Y)-12,64%
Earnings (1Y)162,77%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
4,74%
ROIC7,09%
Net Margin3,28%
Op. Margin9,75%
Veiligheid
Debt / Equity
0,49
Current Ratio2,39
Interest Coverage5,19
Waardering
P/E Ratio
91,85
P/B Ratio4,35
EV/EBITDA33,82
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -12,64% | Revenue Growth (3Y) | -0,73% |
| Earnings Growth (1Y) | 162,77% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 7,01% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 240,24M | Net Income (TTM) | 7,88M |
| ROE | 4,74% | ROA | 2,51% |
| Gross Margin | 41,00% | Operating Margin | 9,75% |
| Net Margin | 3,28% | Free Cash Flow (TTM) | 15,65M |
| ROIC | 7,09% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,49 | Current Ratio | 2,39 |
| Interest Coverage | 5,19 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 91,85 | P/B Ratio | 4,35 |
| P/S Ratio | 3,01 | PEG Ratio | 0,62 |
| EV/EBITDA | 33,82 | Dividend Yield | 0,01% |
| Market Cap | 724,04M | Enterprise Value | 791,94M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 240,24M | 275,00M | 243,80M | 228,58M | 183,22M |
| Net Income | 7,88M | 3,00M | -14,40M | -6,81M | -25,28M |
| EPS (Diluted) | 0,26 | 0,10 | -0,48 | -0,25 | -0,83 |
| Gross Profit | 98,50M | 105,80M | 85,90M | 66,10M | 59,83M |
| Operating Income | 23,42M | 10,70M | -12,60M | 9,85M | -7,38M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 314,32M | 312,90M | 348,10M | 344,90M | 399,42M |
| Total Liabilities | 147,87M | 146,40M | 188,70M | 136,28M | 193,65M |
| Shareholders' Equity | 166,45M | 166,50M | 159,40M | 210,50M | 205,77M |
| Total Debt | 81,28M | 79,40M | 98,60M | 77,50M | 70,13M |
| Cash & Equivalents | 13,38M | 14,00M | 13,20M | 9,50M | 14,13M |
| Current Assets | 121,02M | 106,30M | 126,20M | 110,10M | 129,13M |
| Current Liabilities | 50,72M | 46,90M | 40,00M | 47,10M | 47,59M |